Haemonetics

(NYSE) HAE

Current Price$76.71

Market Cap$3.50B

Since IPO (1991)+1,217%

5 Year+31%

1 Year+10%

1 Month+37%

Haemonetics Financials at a Glance

Market Cap

$3.50B

Revenue (TTM)

$1.33B

Net Income (TTM)

$97.31M

EPS (TTM)

$2.03

P/E Ratio

37.85

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Price

$76.71

Volume

24,156

Open

$77.94

Price

$76.71

Volume

24,156

Open

$77.94

Previous Close

$76.71

Daily Range

$76.71 - $78.29

52-Week Range

$47.32 - $87.32

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Price

$76.71

Volume

24,156

Open

$77.94

Previous Close

$76.71

Daily Range

$76.71 - $78.29

52-Week Range

$47.32 - $87.32

Estimated Earnings Date

Aug 6, 2026

HAE News

What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year

Jonathan PoncianoMar 20, 2026

Page 1

HAE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Haemonetics

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

3,009

CEO

Christopher A. Simon, MBA

Website

www.haemonetics.com

Headquarters

Boston, MA 02110, US

HAE Financials

Key Financial Metrics (TTM)

Gross Margin

57%

Operating Margin

18%

Net Income Margin

Return on Equity

12%

Return on Capital

11%

Return on Assets

Earnings Yield

2.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.50B

Shares Outstanding

45.45M

Volume

24.16K

Avg. Volume

862.74K

Financials (TTM)

Gross Profit

$743.59M

Operating Income

$241.40M

EBITDA

$312.45M

Operating Cash Flow

$293.22M

Capital Expenditure

-$32.78M

Free Cash Flow

$260.44M

Cash & ST Invst.

$245.44M

Total Debt

$1.22B

Haemonetics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

$346.35M

+4.8%

Gross Profit

$198.21M

+9.0%

Gross Margin

57.23%

N/A

Market Cap

$3.50B

N/A

Market Cap/Employee

$955.77K

N/A

Employees

3,657

N/A

Net Income

-$20.15M

-134.7%

EBITDA

-$23.03M

-123.3%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

$245.44M

-20.0%

Total Debt

$1.22B

-0.0%

Accounts Receivable

$216.86M

+7.0%

Inventory

$306.37M

-16.1%

Long Term Debt

$1.22B

+32.4%

Short Term Debt

$5.02M

-98.3%

Return on Assets

4.06%

N/A

Return on Invested Capital

11.46%

N/A

Free Cash Flow

$53.28M

-47.2%

Operating Cash Flow

$70.94M

-39.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CONConcentra Group Holdings Parent, Inc.

CONConcentra Group Holdings Parent, Inc.$28.15+0.07%

WRBYWarby Parker Inc.

WRBYWarby Parker Inc.$26.38-0.30%

BEAMBeam Therapeutics Inc.

BEAMBeam Therapeutics Inc.$31.12+7.20%

CPRXCatalyst Pharmaceuticals, Inc.

CPRXCatalyst Pharmaceuticals, Inc.$31.37+0.03%

ITGRInteger Holdings Corporation

ITGRInteger Holdings Corporation$90.85-0.14%

PINCPremier, Inc.

PINCPremier, Inc.$28.26+0.32%

LMATLeMaitre Vascular, Inc.

LMATLeMaitre Vascular, Inc.$91.92-0.04%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$192.50+0.20%

NVDANvidia

NVDANvidia$212.15+0.03%

INTCIntel

INTCIntel$127.60+0.02%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$37.72+0.05%

QBTSD-Wave Quantum

QBTSD-Wave Quantum$26.33+0.13%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.89+0.02%

MRVLMarvell Technology

MRVLMarvell Technology$310.41+0.11%

Questions About HAE

What is the current price of Haemonetics?

Haemonetics is trading at $76.71 per share.

What is the 52-week range for Haemonetics?

Over the past 52 weeks, Haemonetics has traded between $47.32 and $87.32.

How much debt does Haemonetics have?

As of the most recent reporting period, Haemonetics reported total debt of $1.27B.

How much cash does Haemonetics have on hand?

Haemonetics reported $245.44M in cash and cash equivalents in its most recent financial results.

What is Haemonetics’s dividend yield?

Haemonetics does not currently have a dividend yield.

Haemonetics

Haemonetics Financials at a Glance

HAE News

What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year

SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million

Why Haemonetics Stock Was on Fire Thursday

Haemonetics (HAE) Q1 Revenue Falls 4%

Why Haemonetics Stock Dived by 15% Today

Why Haemonetics Stock Rallied on Friday

Why Haemonetics Stock Fell 13% Today

Why Baidu, Pandora Media, and Haemonetics Slumped Today

HAE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Haemonetics

HAE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Haemonetics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HAE

What is the current price of Haemonetics?

What is the 52-week range for Haemonetics?

How much debt does Haemonetics have?

How much cash does Haemonetics have on hand?

What is Haemonetics’s dividend yield?

Premium Investing Services